Company signals · Biotech & Pharma
Promomed Group
1 signal in the current window, with MitchelLake's leadership read on each.
Market context: Backdrop: a 98.6 (Neutral) Talent Market Index (down 1.4 on the month) with Asia activity rising (+2.4pts).
Promomed Group: 1 signal in the last 90 days — in line with the Biotech & Pharma median of 1 across 19 tracked companies; 0.1% of MitchelLake's Asia signal flow.
Signals at Promomed Group
More signals across Biotech & Pharma
Geographic Expansion · Asia
Thermo Fisher Scientific →Thermo Fisher Scientific's Manila Shared Services Centre is scaling rapidly from 100 to ~700 employees by 2026, positioning itself as a high-impact regional hub for Asia-Pacific operations with focus on digital transformation and strategic value creation beyond cost efficiency.
Capital Raising · Asia
Legend Biotech →First Beijing Investment Ltd acquired $43.78 million stake (2.3M shares) in Legend Biotech, a cancer cell therapy developer
Partnership · Asia
Bristol Myers Squibb →Bristol Myers Squibb partners with China's Hengrui Pharma on a $15.2 billion deal to advance more than a dozen early-stage drugs
Ma Activity · Asia
Gilead Sciences →Gilead Sciences agreed to acquire Ouro Medicines for up to $2.18 billion, gaining rights to antibody drug licensed from China's Keymed Biosciences
Geographic Expansion · Americas
Novartis AG →Novartis is expanding its U.S. manufacturing footprint by establishing a new site in Texas
Geographic Expansion · EMEA
Cambrex →Cambrex completed initial engineering studies for new large-scale API manufacturing plant expansion in US and Europe
Intelligence powered by Autonodal ↗